Category Archives: Cancer

What You Need to Know about Cytokines in Immuno-Oncology

What You Need to Know about Cytokines in Immuno-Oncology

One of the main approaches to cancer immunotherapy involves cytokines, which serve as messengers for the immune system. Immune cells secrete cytokines, which are proteins or glycoproteins, to strengthen or suppress normal immune functions. Researchers are attempting to take advantage of this regulatory role to boost the activity of macrophages and natural killer cells, as… Read More…

CAR T-Cell Therapy: Engineering Your Immune Cells to Fight Cancer

CAR T-Cell Therapy: Engineering Your Immune Cells to Fight Cancer

One of the most important questions that immuno-oncologists will tackle in the coming years is figuring out where chimeric antigen receptor (CAR) T-cell therapy will fit into the larger picture. Academic centers across the country have been using this technology to successfully treat patients, but adapting this complicated system to a community setting introduces a… Read More…

A Look at the Role Monoclonal Antibodies Play in Immuno-Oncology

A Look at the Role Monoclonal Antibodies Play in Immuno-Oncology

Immuno-oncological research is exploring several different approaches to immunotherapy, including vaccines, checkpoint inhibitors, and monoclonal antibodies. At present, several different types of monoclonal antibody drugs exist, but researchers are still exploring how to employ them most effectively in a treatment plan. The term monoclonal antibody refers to a molecule produced in a laboratory that has… Read More…

The Parker Foundation Launches Cancer Immunotherapy Institute

Led by Silicon Valley entrepreneur and philanthropist Sean Parker, The Parker Foundation recently announced the launch of the Parker Institute for Cancer Immunotherapy. Following the recent loss of his close friend to cancer, Parker wants to figure out how to battle cancer and has particularly focused on the field of immuno-oncology. The friend whom Parker… Read More…

Can New Immunotherapy Research Halt Brain Cancer?

Can New Immunotherapy Research Halt Brain Cancer?

Recently, the National Brain Tumor Society and Oligo Nation announced a $250,000 grant that will fuel a preliminary look at immunotherapy’s applications in the treatment of oligodendroglioma, a rare brain cancer that accounts for about 6 percent of all gliomas. In the United States, there are nearly 2,000 new oligodendroglioma diagnoses each year. Since the… Read More…

2 of the New Studies That Suggest the Benefits of Cancer Immunotherapy

2 of the New Studies That Suggest the Benefits of Cancer Immunotherapy

As new immuno-oncology therapies emerge, they are proving effective against an increasingly wide range of cancers. Importantly, immunotherapies have proven effective in treating previously intractable tumors and rare cancers. The results of continued research increasingly place immuno-oncology at the heart of new anti-cancer tactics. As researchers redouble their efforts to understand what makes the immune… Read More…

3 Approaches to Immuno-Oncology: What You Need to Know

3 Approaches to Immuno-Oncology: What You Need to Know

Traditional approaches to cancer treatment involve surgery, which is the manual removal of abnormal cells during early stages; chemotherapy, which aims to poison the abnormal cells; and irradiation, which “burns” the cells. Unfortunately, these methods are not very targeted, meaning that they also do damage to healthy cells. Older patients or those with complicating diagnoses… Read More…

AstraZeneca Partners with TapImmune for Phase 2 Ovarian Cancer Trial

AstraZeneca Partners with TapImmune for Phase 2 Ovarian Cancer Trial

As the promise of immuno-oncology grows and takes a larger foothold in the realm of cancer treatment, the competition among biotech firms—both large and small—has grown tremendously. The market has been flooded with new partnerships and acquisitions, as different organizations join forces to become the first to bring the next big drug to the market.… Read More…